PT-141 – 10mg

From the USA.

Low Stock
Satisfaction Guaranteed

No questions asked return policy.

Independent Lab Testing

Purity is verified. Click here for more information.

Secure Checkout

Comodo SSL secure checkout.

Fast and Discrete Shipping

Same day USPS 1-3 day Priority Mail shipping for all orders placed before 6pm EST Monday through Friday.

$29.99

Discount per Quantity

Quantity 2 -3 4 -9 10 +
Price $26.99 $23.99 $17.99
  • Description
  • Reviews (3)

Description:

PT-141 is a non-selective agonist of all the melanocortin receptors 1, 3, 4 and 5. Activation of the melanocortin 4 receptor stimulates libido to a very significant degree.


Information:

Names: PT-141, PT 141, Bremelanotide
CAS#: 189691-06-3
Unit Size: 10mg vial
Purity: 98%
CoA: Certificate of Analysis for LOT#: 82939
Storage: Freeze until reconstitution. Refrigerate after reconstitution.
Terms: Research use only.

Selected Research:

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.
https://www.ncbi.nlm.nih.gov/pubmed/12851303

An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
https://www.ncbi.nlm.nih.gov/pubmed/16839319

Bremelanotide: an overview of preclinical CNS effects on female sexual function.
https://www.ncbi.nlm.nih.gov/pubmed/17958619

Melanocortins in the treatment of male and female sexual dysfunction.
https://www.ncbi.nlm.nih.gov/pubmed/17584134

Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response.
https://www.ncbi.nlm.nih.gov/pubmed/15833522

Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study.
https://www.ncbi.nlm.nih.gov/pubmed/18179455

Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial.
https://www.ncbi.nlm.nih.gov/pubmed/27181790

Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra.
https://www.ncbi.nlm.nih.gov/pubmed/14999221

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.
https://www.ncbi.nlm.nih.gov/pubmed/14963471

Melanocortin receptors, melanotropic peptides and penile erection.
https://www.ncbi.nlm.nih.gov/pubmed/17584130

3 reviews for PT-141 – 10mg

  1. 5 out of 5

  2. 5 out of 5

  3. 5 out of 5


Add a review